Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Eli Lilly and Company LLY
Healthcare - Drug Manufacturers - General - NYSE - US
Watchlist
$ 746.2
-4.93 %
$ 708 B
Market Cap
80.41
P/E
Price Target
Average
27.18%
Revenue Forecast
Estimate
26.93%
EBIT
Estimate
20.99%
Net Income
Estimate
62.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Eli Lilly and Company
Wall Street analysts predict an average 1-year price target for
LLY
of
$949
, with forecasts ranging from a low of
$535
to a high of
$1.15 K
.
LLY Lowest Price Target
Wall Street Target
535 USD
-28.30%
LLY Average Price Target
Wall Street Target
949 USD
27.18%
LLY Highest Price Target
Wall Street Target
1.15 K USD
54.11%
REVENUE FORECAST
Revenue Forecast Chart
LLY
EBIT FORECAST
EBIT Forecast Chart
LLY
NET INCOME FORECAST
Net Income Chart
LLY
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan